News
The health sector sees dynamic shifts with Thailand's poultry industry set for growth, breakthrough breast cancer treatments ...
The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...
BANGKOK (Reuters) -Novo Nordisk (NOVO-B.CO, NVO) has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking ...
Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...
If you’re exploring diabetes or weight-loss medications, Ozempic and Wegovy have become two popular options of injectable treatments. Both medications support blood sugar control and weight loss ...
The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.
“If in fact they keep their commitment, will Novo Nordisk substantially lower the list price of Ozempic and Wegovy in the U.S.?” Sanders, who chairs the committee, asked. Jørgensen initially ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...
Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results